Schedule 13D ownership disclosure

Brickell Biotech, Inc.

Security class unavailable · CUSIP: 10802T105

Event date: 2019-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,013,232
Percent of class
13.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-19-005883
Form type
SC 13D
Filer
Fresh Tracks Therapeutics, Inc.
CIK
CIK 819050
Filed
Sep 16, 2019
Reporting period
Aug 31, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub